ELOX Stock Summary and Trading Ideas (Eloxx Pharmaceuticals | NASDAQ:ELOX)

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Eloxx Pharmaceuticals trades on the NASDAQ stock market under the symbol ELOX.

As of October 2, 2026, ELOX stock price declined to $15.51 with 17,507 million shares trading.

ELOX has a beta of 0.78, meaning it tends to be less sensitive to market movements. ELOX has a correlation of 0.01 to the broad based SPY ETF.

ELOX has a market cap of $53.30 million. This is considered a Micro Cap stock.

The top ETF exchange traded funds that ELOX belongs to (by Net Assets): VTI, VXF.

ELOX support price is $14.38 and resistance is $17.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ELOX shares will trade within this expected range on the day.